nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP2E1—lung cancer	0.33	1	CbGaD
Ethosuximide—CYP3A5—Gefitinib—lung cancer	0.0362	0.0798	CbGbCtD
Ethosuximide—CYP3A5—Teniposide—lung cancer	0.0351	0.0774	CbGbCtD
Ethosuximide—CYP3A7—Paclitaxel—lung cancer	0.0261	0.0576	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0261	0.0576	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0257	0.0568	CbGbCtD
Ethosuximide—CYP3A7—Irinotecan—lung cancer	0.0257	0.0568	CbGbCtD
Ethosuximide—CYP3A5—Crizotinib—lung cancer	0.0222	0.0489	CbGbCtD
Ethosuximide—CYP3A5—Erlotinib—lung cancer	0.0214	0.0472	CbGbCtD
Ethosuximide—CYP2E1—Etoposide—lung cancer	0.0199	0.0439	CbGbCtD
Ethosuximide—CYP3A5—Paclitaxel—lung cancer	0.0196	0.0432	CbGbCtD
Ethosuximide—CYP3A5—Irinotecan—lung cancer	0.0193	0.0426	CbGbCtD
Ethosuximide—CYP3A7—Docetaxel—lung cancer	0.0189	0.0416	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0189	0.0416	CbGbCtD
Ethosuximide—CYP3A5—Etoposide—lung cancer	0.0155	0.0341	CbGbCtD
Ethosuximide—CYP3A4—Topotecan—lung cancer	0.0154	0.034	CbGbCtD
Ethosuximide—CYP3A5—Docetaxel—lung cancer	0.0141	0.0312	CbGbCtD
Ethosuximide—CYP3A4—Gefitinib—lung cancer	0.0141	0.0311	CbGbCtD
Ethosuximide—CYP3A4—Teniposide—lung cancer	0.0137	0.0302	CbGbCtD
Ethosuximide—CYP3A4—Vinorelbine—lung cancer	0.0109	0.024	CbGbCtD
Ethosuximide—CYP3A4—Crizotinib—lung cancer	0.00864	0.0191	CbGbCtD
Ethosuximide—CYP3A4—Erlotinib—lung cancer	0.00834	0.0184	CbGbCtD
Ethosuximide—CYP3A4—Paclitaxel—lung cancer	0.00763	0.0168	CbGbCtD
Ethosuximide—CYP3A4—Irinotecan—lung cancer	0.00753	0.0166	CbGbCtD
Ethosuximide—CYP3A4—Vinblastine—lung cancer	0.00669	0.0148	CbGbCtD
Ethosuximide—CYP3A4—Etoposide—lung cancer	0.00603	0.0133	CbGbCtD
Ethosuximide—CYP3A4—Docetaxel—lung cancer	0.00552	0.0122	CbGbCtD
Ethosuximide—CYP3A4—Doxorubicin—lung cancer	0.00411	0.00908	CbGbCtD
Ethosuximide—Leukopenia—Gemcitabine—lung cancer	0.000214	0.00179	CcSEcCtD
Ethosuximide—Immune system disorder—Etoposide—lung cancer	0.000211	0.00178	CcSEcCtD
Ethosuximide—Mediastinal disorder—Etoposide—lung cancer	0.000211	0.00177	CcSEcCtD
Ethosuximide—Decreased appetite—Vinorelbine—lung cancer	0.000211	0.00177	CcSEcCtD
Ethosuximide—Mental disability—Doxorubicin—lung cancer	0.00021	0.00176	CcSEcCtD
Ethosuximide—Asthenia—Vinblastine—lung cancer	0.000209	0.00176	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000209	0.00176	CcSEcCtD
Ethosuximide—Fatigue—Vinorelbine—lung cancer	0.000209	0.00176	CcSEcCtD
Ethosuximide—Hypersensitivity—Topotecan—lung cancer	0.000209	0.00175	CcSEcCtD
Ethosuximide—Immune system disorder—Paclitaxel—lung cancer	0.000207	0.00174	CcSEcCtD
Ethosuximide—Mediastinal disorder—Paclitaxel—lung cancer	0.000207	0.00174	CcSEcCtD
Ethosuximide—Lethargy—Methotrexate—lung cancer	0.000207	0.00174	CcSEcCtD
Ethosuximide—Asthenia—Topotecan—lung cancer	0.000203	0.00171	CcSEcCtD
Ethosuximide—Agranulocytosis—Docetaxel—lung cancer	0.000202	0.0017	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000202	0.00169	CcSEcCtD
Ethosuximide—Asthenia—Erlotinib—lung cancer	0.000201	0.00169	CcSEcCtD
Ethosuximide—Mental disorder—Paclitaxel—lung cancer	0.000201	0.00169	CcSEcCtD
Ethosuximide—Malnutrition—Paclitaxel—lung cancer	0.0002	0.00168	CcSEcCtD
Ethosuximide—Diarrhoea—Vinblastine—lung cancer	0.0002	0.00168	CcSEcCtD
Ethosuximide—Leukopenia—Cisplatin—lung cancer	0.000199	0.00167	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Vinorelbine—lung cancer	0.000198	0.00166	CcSEcCtD
Ethosuximide—Nervous system disorder—Irinotecan—lung cancer	0.000196	0.00165	CcSEcCtD
Ethosuximide—Muscle spasms—Etoposide—lung cancer	0.000196	0.00165	CcSEcCtD
Ethosuximide—Diarrhoea—Topotecan—lung cancer	0.000194	0.00163	CcSEcCtD
Ethosuximide—Irritability—Methotrexate—lung cancer	0.000193	0.00162	CcSEcCtD
Ethosuximide—Dizziness—Vinblastine—lung cancer	0.000193	0.00162	CcSEcCtD
Ethosuximide—Urticaria—Vinorelbine—lung cancer	0.000193	0.00162	CcSEcCtD
Ethosuximide—Urinary tract disorder—Docetaxel—lung cancer	0.000192	0.00161	CcSEcCtD
Ethosuximide—Muscle spasms—Paclitaxel—lung cancer	0.000192	0.00161	CcSEcCtD
Ethosuximide—Diarrhoea—Erlotinib—lung cancer	0.000192	0.00161	CcSEcCtD
Ethosuximide—Abdominal pain—Vinorelbine—lung cancer	0.000192	0.00161	CcSEcCtD
Ethosuximide—Connective tissue disorder—Docetaxel—lung cancer	0.000191	0.00161	CcSEcCtD
Ethosuximide—Nervous system disorder—Gemcitabine—lung cancer	0.000191	0.0016	CcSEcCtD
Ethosuximide—Urethral disorder—Docetaxel—lung cancer	0.000191	0.0016	CcSEcCtD
Ethosuximide—Anorexia—Irinotecan—lung cancer	0.000191	0.0016	CcSEcCtD
Ethosuximide—Ataxia—Methotrexate—lung cancer	0.000191	0.0016	CcSEcCtD
Ethosuximide—Skin disorder—Gemcitabine—lung cancer	0.000189	0.00159	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000188	0.00158	CcSEcCtD
Ethosuximide—Dizziness—Topotecan—lung cancer	0.000187	0.00157	CcSEcCtD
Ethosuximide—Anorexia—Gemcitabine—lung cancer	0.000186	0.00156	CcSEcCtD
Ethosuximide—Vomiting—Vinblastine—lung cancer	0.000186	0.00156	CcSEcCtD
Ethosuximide—Dizziness—Erlotinib—lung cancer	0.000185	0.00156	CcSEcCtD
Ethosuximide—Erythema multiforme—Docetaxel—lung cancer	0.000184	0.00154	CcSEcCtD
Ethosuximide—Agitation—Paclitaxel—lung cancer	0.000184	0.00154	CcSEcCtD
Ethosuximide—Breast disorder—Methotrexate—lung cancer	0.000183	0.00154	CcSEcCtD
Ethosuximide—Headache—Vinblastine—lung cancer	0.000183	0.00153	CcSEcCtD
Ethosuximide—Leukopenia—Etoposide—lung cancer	0.000182	0.00153	CcSEcCtD
Ethosuximide—Eye disorder—Docetaxel—lung cancer	0.000182	0.00153	CcSEcCtD
Ethosuximide—Vomiting—Topotecan—lung cancer	0.00018	0.00151	CcSEcCtD
Ethosuximide—Lethargy—Doxorubicin—lung cancer	0.000179	0.0015	CcSEcCtD
Ethosuximide—Leukopenia—Paclitaxel—lung cancer	0.000179	0.0015	CcSEcCtD
Ethosuximide—Rash—Topotecan—lung cancer	0.000179	0.0015	CcSEcCtD
Ethosuximide—Hypersensitivity—Vinorelbine—lung cancer	0.000179	0.0015	CcSEcCtD
Ethosuximide—Dermatitis—Topotecan—lung cancer	0.000179	0.0015	CcSEcCtD
Ethosuximide—Vomiting—Erlotinib—lung cancer	0.000178	0.0015	CcSEcCtD
Ethosuximide—Nervous system disorder—Cisplatin—lung cancer	0.000178	0.0015	CcSEcCtD
Ethosuximide—Somnolence—Irinotecan—lung cancer	0.000178	0.00149	CcSEcCtD
Ethosuximide—Headache—Topotecan—lung cancer	0.000178	0.00149	CcSEcCtD
Ethosuximide—Rash—Erlotinib—lung cancer	0.000177	0.00148	CcSEcCtD
Ethosuximide—Dermatitis—Erlotinib—lung cancer	0.000177	0.00148	CcSEcCtD
Ethosuximide—Skin disorder—Cisplatin—lung cancer	0.000176	0.00148	CcSEcCtD
Ethosuximide—Immune system disorder—Docetaxel—lung cancer	0.000176	0.00148	CcSEcCtD
Ethosuximide—Headache—Erlotinib—lung cancer	0.000176	0.00148	CcSEcCtD
Ethosuximide—Mediastinal disorder—Docetaxel—lung cancer	0.000175	0.00147	CcSEcCtD
Ethosuximide—Asthenia—Vinorelbine—lung cancer	0.000174	0.00146	CcSEcCtD
Ethosuximide—Decreased appetite—Irinotecan—lung cancer	0.000174	0.00146	CcSEcCtD
Ethosuximide—Eosinophilia—Methotrexate—lung cancer	0.000173	0.00146	CcSEcCtD
Ethosuximide—Nausea—Vinblastine—lung cancer	0.000173	0.00146	CcSEcCtD
Ethosuximide—Somnolence—Gemcitabine—lung cancer	0.000173	0.00145	CcSEcCtD
Ethosuximide—Anorexia—Cisplatin—lung cancer	0.000173	0.00145	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Irinotecan—lung cancer	0.000173	0.00145	CcSEcCtD
Ethosuximide—Fatigue—Irinotecan—lung cancer	0.000172	0.00145	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000172	0.00145	CcSEcCtD
Ethosuximide—Mental disorder—Docetaxel—lung cancer	0.00017	0.00143	CcSEcCtD
Ethosuximide—Malnutrition—Docetaxel—lung cancer	0.000169	0.00142	CcSEcCtD
Ethosuximide—Decreased appetite—Gemcitabine—lung cancer	0.000169	0.00142	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000169	0.00142	CcSEcCtD
Ethosuximide—Nausea—Topotecan—lung cancer	0.000168	0.00141	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000168	0.00141	CcSEcCtD
Ethosuximide—Abdominal discomfort—Methotrexate—lung cancer	0.000168	0.00141	CcSEcCtD
Ethosuximide—Fatigue—Gemcitabine—lung cancer	0.000168	0.00141	CcSEcCtD
Ethosuximide—Nausea—Erlotinib—lung cancer	0.000167	0.0014	CcSEcCtD
Ethosuximide—Pancytopenia—Methotrexate—lung cancer	0.000166	0.0014	CcSEcCtD
Ethosuximide—Diarrhoea—Vinorelbine—lung cancer	0.000166	0.00139	CcSEcCtD
Ethosuximide—Ataxia—Doxorubicin—lung cancer	0.000165	0.00139	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Irinotecan—lung cancer	0.000164	0.00137	CcSEcCtD
Ethosuximide—Muscle spasms—Docetaxel—lung cancer	0.000163	0.00137	CcSEcCtD
Ethosuximide—Skin disorder—Etoposide—lung cancer	0.000162	0.00136	CcSEcCtD
Ethosuximide—Dizziness—Vinorelbine—lung cancer	0.00016	0.00135	CcSEcCtD
Ethosuximide—Abdominal pain upper—Doxorubicin—lung cancer	0.00016	0.00135	CcSEcCtD
Ethosuximide—Nervous system disorder—Paclitaxel—lung cancer	0.00016	0.00134	CcSEcCtD
Ethosuximide—Breast disorder—Doxorubicin—lung cancer	0.000159	0.00133	CcSEcCtD
Ethosuximide—Anorexia—Etoposide—lung cancer	0.000159	0.00133	CcSEcCtD
Ethosuximide—Skin disorder—Paclitaxel—lung cancer	0.000158	0.00133	CcSEcCtD
Ethosuximide—Abdominal pain—Irinotecan—lung cancer	0.000158	0.00133	CcSEcCtD
Ethosuximide—Decreased appetite—Cisplatin—lung cancer	0.000158	0.00133	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Cisplatin—lung cancer	0.000157	0.00132	CcSEcCtD
Ethosuximide—Drowsiness—Methotrexate—lung cancer	0.000156	0.00131	CcSEcCtD
Ethosuximide—Anorexia—Paclitaxel—lung cancer	0.000155	0.00131	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000155	0.0013	CcSEcCtD
Ethosuximide—Vomiting—Vinorelbine—lung cancer	0.000154	0.00129	CcSEcCtD
Ethosuximide—Rash—Vinorelbine—lung cancer	0.000153	0.00128	CcSEcCtD
Ethosuximide—Dermatitis—Vinorelbine—lung cancer	0.000153	0.00128	CcSEcCtD
Ethosuximide—Headache—Vinorelbine—lung cancer	0.000152	0.00128	CcSEcCtD
Ethosuximide—Leukopenia—Docetaxel—lung cancer	0.000152	0.00127	CcSEcCtD
Ethosuximide—Eosinophilia—Doxorubicin—lung cancer	0.00015	0.00126	CcSEcCtD
Ethosuximide—Haematuria—Methotrexate—lung cancer	0.000149	0.00125	CcSEcCtD
Ethosuximide—Somnolence—Etoposide—lung cancer	0.000148	0.00124	CcSEcCtD
Ethosuximide—Hypersensitivity—Irinotecan—lung cancer	0.000147	0.00124	CcSEcCtD
Ethosuximide—Agranulocytosis—Methotrexate—lung cancer	0.000146	0.00122	CcSEcCtD
Ethosuximide—Somnolence—Paclitaxel—lung cancer	0.000145	0.00122	CcSEcCtD
Ethosuximide—Decreased appetite—Etoposide—lung cancer	0.000145	0.00121	CcSEcCtD
Ethosuximide—Pancytopenia—Doxorubicin—lung cancer	0.000144	0.00121	CcSEcCtD
Ethosuximide—Nausea—Vinorelbine—lung cancer	0.000144	0.00121	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Etoposide—lung cancer	0.000144	0.00121	CcSEcCtD
Ethosuximide—Asthenia—Irinotecan—lung cancer	0.000143	0.0012	CcSEcCtD
Ethosuximide—Fatigue—Etoposide—lung cancer	0.000143	0.0012	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000143	0.0012	CcSEcCtD
Ethosuximide—Decreased appetite—Paclitaxel—lung cancer	0.000142	0.00119	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000141	0.00118	CcSEcCtD
Ethosuximide—Fatigue—Paclitaxel—lung cancer	0.000141	0.00118	CcSEcCtD
Ethosuximide—Asthenia—Gemcitabine—lung cancer	0.00014	0.00117	CcSEcCtD
Ethosuximide—Urinary tract disorder—Methotrexate—lung cancer	0.000138	0.00116	CcSEcCtD
Ethosuximide—Urethral disorder—Methotrexate—lung cancer	0.000137	0.00115	CcSEcCtD
Ethosuximide—Weight decreased—Doxorubicin—lung cancer	0.000137	0.00115	CcSEcCtD
Ethosuximide—Diarrhoea—Irinotecan—lung cancer	0.000137	0.00115	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Etoposide—lung cancer	0.000136	0.00114	CcSEcCtD
Ethosuximide—Nervous system disorder—Docetaxel—lung cancer	0.000136	0.00114	CcSEcCtD
Ethosuximide—Drowsiness—Doxorubicin—lung cancer	0.000135	0.00114	CcSEcCtD
Ethosuximide—Skin disorder—Docetaxel—lung cancer	0.000134	0.00113	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000134	0.00113	CcSEcCtD
Ethosuximide—Hypersensitivity—Cisplatin—lung cancer	0.000134	0.00112	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Paclitaxel—lung cancer	0.000133	0.00112	CcSEcCtD
Ethosuximide—Diarrhoea—Gemcitabine—lung cancer	0.000133	0.00112	CcSEcCtD
Ethosuximide—Erythema multiforme—Methotrexate—lung cancer	0.000133	0.00111	CcSEcCtD
Ethosuximide—Dizziness—Irinotecan—lung cancer	0.000132	0.00111	CcSEcCtD
Ethosuximide—Urticaria—Etoposide—lung cancer	0.000132	0.00111	CcSEcCtD
Ethosuximide—Anorexia—Docetaxel—lung cancer	0.000132	0.00111	CcSEcCtD
Ethosuximide—Abdominal pain—Etoposide—lung cancer	0.000131	0.0011	CcSEcCtD
Ethosuximide—Eye disorder—Methotrexate—lung cancer	0.000131	0.0011	CcSEcCtD
Ethosuximide—Asthenia—Cisplatin—lung cancer	0.00013	0.00109	CcSEcCtD
Ethosuximide—Urticaria—Paclitaxel—lung cancer	0.00013	0.00109	CcSEcCtD
Ethosuximide—Haematuria—Doxorubicin—lung cancer	0.000129	0.00108	CcSEcCtD
Ethosuximide—Abdominal pain—Paclitaxel—lung cancer	0.000129	0.00108	CcSEcCtD
Ethosuximide—Vomiting—Irinotecan—lung cancer	0.000127	0.00107	CcSEcCtD
Ethosuximide—Immune system disorder—Methotrexate—lung cancer	0.000127	0.00106	CcSEcCtD
Ethosuximide—Mediastinal disorder—Methotrexate—lung cancer	0.000126	0.00106	CcSEcCtD
Ethosuximide—Agranulocytosis—Doxorubicin—lung cancer	0.000126	0.00106	CcSEcCtD
Ethosuximide—Rash—Irinotecan—lung cancer	0.000126	0.00106	CcSEcCtD
Ethosuximide—Dermatitis—Irinotecan—lung cancer	0.000126	0.00106	CcSEcCtD
Ethosuximide—Headache—Irinotecan—lung cancer	0.000125	0.00105	CcSEcCtD
Ethosuximide—Diarrhoea—Cisplatin—lung cancer	0.000124	0.00104	CcSEcCtD
Ethosuximide—Vomiting—Gemcitabine—lung cancer	0.000124	0.00104	CcSEcCtD
Ethosuximide—Somnolence—Docetaxel—lung cancer	0.000123	0.00103	CcSEcCtD
Ethosuximide—Mental disorder—Methotrexate—lung cancer	0.000123	0.00103	CcSEcCtD
Ethosuximide—Rash—Gemcitabine—lung cancer	0.000123	0.00103	CcSEcCtD
Ethosuximide—Dermatitis—Gemcitabine—lung cancer	0.000123	0.00103	CcSEcCtD
Ethosuximide—Hypersensitivity—Etoposide—lung cancer	0.000123	0.00103	CcSEcCtD
Ethosuximide—Malnutrition—Methotrexate—lung cancer	0.000122	0.00103	CcSEcCtD
Ethosuximide—Headache—Gemcitabine—lung cancer	0.000122	0.00102	CcSEcCtD
Ethosuximide—Decreased appetite—Docetaxel—lung cancer	0.00012	0.00101	CcSEcCtD
Ethosuximide—Hypersensitivity—Paclitaxel—lung cancer	0.00012	0.00101	CcSEcCtD
Ethosuximide—Urinary tract disorder—Doxorubicin—lung cancer	0.00012	0.00101	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000119	0.001	CcSEcCtD
Ethosuximide—Asthenia—Etoposide—lung cancer	0.000119	0.001	CcSEcCtD
Ethosuximide—Connective tissue disorder—Doxorubicin—lung cancer	0.000119	0.001	CcSEcCtD
Ethosuximide—Fatigue—Docetaxel—lung cancer	0.000119	0.001	CcSEcCtD
Ethosuximide—Urethral disorder—Doxorubicin—lung cancer	0.000119	0.000999	CcSEcCtD
Ethosuximide—Nausea—Irinotecan—lung cancer	0.000119	0.000997	CcSEcCtD
Ethosuximide—Asthenia—Paclitaxel—lung cancer	0.000117	0.000983	CcSEcCtD
Ethosuximide—Nausea—Gemcitabine—lung cancer	0.000116	0.000972	CcSEcCtD
Ethosuximide—Vomiting—Cisplatin—lung cancer	0.000115	0.000969	CcSEcCtD
Ethosuximide—Erythema multiforme—Doxorubicin—lung cancer	0.000115	0.000964	CcSEcCtD
Ethosuximide—Rash—Cisplatin—lung cancer	0.000114	0.000961	CcSEcCtD
Ethosuximide—Dermatitis—Cisplatin—lung cancer	0.000114	0.00096	CcSEcCtD
Ethosuximide—Diarrhoea—Etoposide—lung cancer	0.000114	0.000956	CcSEcCtD
Ethosuximide—Eye disorder—Doxorubicin—lung cancer	0.000113	0.000953	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Docetaxel—lung cancer	0.000113	0.000949	CcSEcCtD
Ethosuximide—Diarrhoea—Paclitaxel—lung cancer	0.000112	0.000937	CcSEcCtD
Ethosuximide—Dizziness—Etoposide—lung cancer	0.00011	0.000924	CcSEcCtD
Ethosuximide—Immune system disorder—Doxorubicin—lung cancer	0.00011	0.000921	CcSEcCtD
Ethosuximide—Mediastinal disorder—Doxorubicin—lung cancer	0.000109	0.000919	CcSEcCtD
Ethosuximide—Abdominal pain—Docetaxel—lung cancer	0.000109	0.000918	CcSEcCtD
Ethosuximide—Leukopenia—Methotrexate—lung cancer	0.000109	0.000918	CcSEcCtD
Ethosuximide—Dizziness—Paclitaxel—lung cancer	0.000108	0.000906	CcSEcCtD
Ethosuximide—Nausea—Cisplatin—lung cancer	0.000108	0.000906	CcSEcCtD
Ethosuximide—Mental disorder—Doxorubicin—lung cancer	0.000106	0.000893	CcSEcCtD
Ethosuximide—Vomiting—Etoposide—lung cancer	0.000106	0.000888	CcSEcCtD
Ethosuximide—Malnutrition—Doxorubicin—lung cancer	0.000106	0.000888	CcSEcCtD
Ethosuximide—Rash—Etoposide—lung cancer	0.000105	0.000881	CcSEcCtD
Ethosuximide—Dermatitis—Etoposide—lung cancer	0.000105	0.00088	CcSEcCtD
Ethosuximide—Headache—Etoposide—lung cancer	0.000104	0.000875	CcSEcCtD
Ethosuximide—Vomiting—Paclitaxel—lung cancer	0.000104	0.000871	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000103	0.000867	CcSEcCtD
Ethosuximide—Rash—Paclitaxel—lung cancer	0.000103	0.000863	CcSEcCtD
Ethosuximide—Dermatitis—Paclitaxel—lung cancer	0.000103	0.000863	CcSEcCtD
Ethosuximide—Headache—Paclitaxel—lung cancer	0.000102	0.000858	CcSEcCtD
Ethosuximide—Hypersensitivity—Docetaxel—lung cancer	0.000102	0.000855	CcSEcCtD
Ethosuximide—Muscle spasms—Doxorubicin—lung cancer	0.000102	0.000853	CcSEcCtD
Ethosuximide—Asthenia—Docetaxel—lung cancer	9.92e-05	0.000833	CcSEcCtD
Ethosuximide—Nausea—Etoposide—lung cancer	9.88e-05	0.00083	CcSEcCtD
Ethosuximide—Nervous system disorder—Methotrexate—lung cancer	9.77e-05	0.00082	CcSEcCtD
Ethosuximide—Agitation—Doxorubicin—lung cancer	9.71e-05	0.000816	CcSEcCtD
Ethosuximide—Nausea—Paclitaxel—lung cancer	9.69e-05	0.000813	CcSEcCtD
Ethosuximide—Skin disorder—Methotrexate—lung cancer	9.68e-05	0.000813	CcSEcCtD
Ethosuximide—Anorexia—Methotrexate—lung cancer	9.5e-05	0.000797	CcSEcCtD
Ethosuximide—Leukopenia—Doxorubicin—lung cancer	9.46e-05	0.000795	CcSEcCtD
Ethosuximide—Diarrhoea—Docetaxel—lung cancer	9.46e-05	0.000794	CcSEcCtD
Ethosuximide—Dizziness—Docetaxel—lung cancer	9.14e-05	0.000768	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	8.94e-05	0.00075	CcSEcCtD
Ethosuximide—Somnolence—Methotrexate—lung cancer	8.86e-05	0.000744	CcSEcCtD
Ethosuximide—Vomiting—Docetaxel—lung cancer	8.79e-05	0.000738	CcSEcCtD
Ethosuximide—Rash—Docetaxel—lung cancer	8.72e-05	0.000732	CcSEcCtD
Ethosuximide—Dermatitis—Docetaxel—lung cancer	8.71e-05	0.000731	CcSEcCtD
Ethosuximide—Decreased appetite—Methotrexate—lung cancer	8.66e-05	0.000727	CcSEcCtD
Ethosuximide—Headache—Docetaxel—lung cancer	8.66e-05	0.000727	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Methotrexate—lung cancer	8.6e-05	0.000722	CcSEcCtD
Ethosuximide—Fatigue—Methotrexate—lung cancer	8.59e-05	0.000721	CcSEcCtD
Ethosuximide—Nervous system disorder—Doxorubicin—lung cancer	8.46e-05	0.00071	CcSEcCtD
Ethosuximide—Skin disorder—Doxorubicin—lung cancer	8.38e-05	0.000704	CcSEcCtD
Ethosuximide—Anorexia—Doxorubicin—lung cancer	8.22e-05	0.000691	CcSEcCtD
Ethosuximide—Nausea—Docetaxel—lung cancer	8.21e-05	0.000689	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Methotrexate—lung cancer	8.15e-05	0.000684	CcSEcCtD
Ethosuximide—Urticaria—Methotrexate—lung cancer	7.91e-05	0.000665	CcSEcCtD
Ethosuximide—Abdominal pain—Methotrexate—lung cancer	7.88e-05	0.000661	CcSEcCtD
Ethosuximide—Somnolence—Doxorubicin—lung cancer	7.67e-05	0.000644	CcSEcCtD
Ethosuximide—Decreased appetite—Doxorubicin—lung cancer	7.5e-05	0.00063	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Doxorubicin—lung cancer	7.45e-05	0.000625	CcSEcCtD
Ethosuximide—Fatigue—Doxorubicin—lung cancer	7.44e-05	0.000625	CcSEcCtD
Ethosuximide—Hypersensitivity—Methotrexate—lung cancer	7.34e-05	0.000616	CcSEcCtD
Ethosuximide—Asthenia—Methotrexate—lung cancer	7.15e-05	0.0006	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Doxorubicin—lung cancer	7.05e-05	0.000592	CcSEcCtD
Ethosuximide—Urticaria—Doxorubicin—lung cancer	6.85e-05	0.000575	CcSEcCtD
Ethosuximide—Abdominal pain—Doxorubicin—lung cancer	6.82e-05	0.000573	CcSEcCtD
Ethosuximide—Diarrhoea—Methotrexate—lung cancer	6.82e-05	0.000572	CcSEcCtD
Ethosuximide—Dizziness—Methotrexate—lung cancer	6.59e-05	0.000553	CcSEcCtD
Ethosuximide—Hypersensitivity—Doxorubicin—lung cancer	6.36e-05	0.000534	CcSEcCtD
Ethosuximide—Vomiting—Methotrexate—lung cancer	6.33e-05	0.000532	CcSEcCtD
Ethosuximide—Rash—Methotrexate—lung cancer	6.28e-05	0.000527	CcSEcCtD
Ethosuximide—Dermatitis—Methotrexate—lung cancer	6.28e-05	0.000527	CcSEcCtD
Ethosuximide—Headache—Methotrexate—lung cancer	6.24e-05	0.000524	CcSEcCtD
Ethosuximide—Asthenia—Doxorubicin—lung cancer	6.19e-05	0.00052	CcSEcCtD
Ethosuximide—Nausea—Methotrexate—lung cancer	5.92e-05	0.000497	CcSEcCtD
Ethosuximide—Diarrhoea—Doxorubicin—lung cancer	5.9e-05	0.000496	CcSEcCtD
Ethosuximide—Dizziness—Doxorubicin—lung cancer	5.7e-05	0.000479	CcSEcCtD
Ethosuximide—Vomiting—Doxorubicin—lung cancer	5.49e-05	0.000461	CcSEcCtD
Ethosuximide—Rash—Doxorubicin—lung cancer	5.44e-05	0.000457	CcSEcCtD
Ethosuximide—Dermatitis—Doxorubicin—lung cancer	5.43e-05	0.000456	CcSEcCtD
Ethosuximide—Headache—Doxorubicin—lung cancer	5.4e-05	0.000454	CcSEcCtD
Ethosuximide—Nausea—Doxorubicin—lung cancer	5.12e-05	0.00043	CcSEcCtD
Ethosuximide—CYP3A4—Biological oxidations—GCLC—lung cancer	3.37e-05	0.000343	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP2A6—lung cancer	3.37e-05	0.000343	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—IL6—lung cancer	3.33e-05	0.000339	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ATP5H—lung cancer	3.31e-05	0.000337	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ATP5H—lung cancer	3.31e-05	0.000337	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—POMC—lung cancer	3.3e-05	0.000336	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—POMC—lung cancer	3.3e-05	0.000336	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTM2—lung cancer	3.26e-05	0.000332	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CNDP2—lung cancer	3.26e-05	0.000332	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MAPK3—lung cancer	3.25e-05	0.000331	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—STK11—lung cancer	3.22e-05	0.000328	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MTMR3—lung cancer	3.17e-05	0.000323	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PGAM1—lung cancer	3.09e-05	0.000315	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—EGFR—lung cancer	3.09e-05	0.000315	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GSTP1—lung cancer	2.98e-05	0.000304	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PLBD1—lung cancer	2.95e-05	0.000301	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2A7—lung cancer	2.95e-05	0.0003	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PLBD1—lung cancer	2.95e-05	0.0003	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—KRAS—lung cancer	2.92e-05	0.000297	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CAT—lung cancer	2.9e-05	0.000295	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	2.89e-05	0.000294	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SDC4—lung cancer	2.89e-05	0.000294	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP2E1—lung cancer	2.86e-05	0.000291	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ABCB1—lung cancer	2.82e-05	0.000287	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	2.82e-05	0.000287	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—TYMS—lung cancer	2.77e-05	0.000282	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GSTM1—lung cancer	2.74e-05	0.000279	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HSD17B10—lung cancer	2.7e-05	0.000275	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HSD17B10—lung cancer	2.7e-05	0.000275	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—RRM1—lung cancer	2.63e-05	0.000268	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTA3—lung cancer	2.63e-05	0.000268	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP1A1—lung cancer	2.6e-05	0.000264	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ERCC2—lung cancer	2.58e-05	0.000262	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CKB—lung cancer	2.51e-05	0.000256	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CKB—lung cancer	2.51e-05	0.000255	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—HRAS—lung cancer	2.48e-05	0.000253	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—B4GALT5—lung cancer	2.47e-05	0.000252	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTA4—lung cancer	2.4e-05	0.000245	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—IL6—lung cancer	2.37e-05	0.000242	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTM2—lung cancer	2.36e-05	0.00024	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CNDP2—lung cancer	2.36e-05	0.00024	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTP1—lung cancer	2.36e-05	0.00024	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTM2—lung cancer	2.36e-05	0.00024	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CNDP2—lung cancer	2.36e-05	0.00024	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTA2—lung cancer	2.34e-05	0.000238	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	2.33e-05	0.000237	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MTMR3—lung cancer	2.3e-05	0.000234	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MTMR3—lung cancer	2.29e-05	0.000233	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTA1—lung cancer	2.26e-05	0.00023	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PGAM1—lung cancer	2.24e-05	0.000228	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ABCC3—lung cancer	2.23e-05	0.000228	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PGAM1—lung cancer	2.23e-05	0.000227	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—APOA1—lung cancer	2.23e-05	0.000227	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—AKT1—lung cancer	2.19e-05	0.000223	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.17e-05	0.000221	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKR1C1—lung cancer	2.16e-05	0.00022	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.14e-05	0.000218	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP2A7—lung cancer	2.14e-05	0.000217	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2A7—lung cancer	2.13e-05	0.000217	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—UGT1A1—lung cancer	2.1e-05	0.000214	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SDC4—lung cancer	2.09e-05	0.000213	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SDC4—lung cancer	2.09e-05	0.000212	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.06e-05	0.000209	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CG—lung cancer	2.03e-05	0.000207	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.03e-05	0.000206	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GNG11—lung cancer	2.03e-05	0.000206	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—POMC—lung cancer	1.94e-05	0.000197	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALDOA—lung cancer	1.93e-05	0.000196	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—RRM1—lung cancer	1.9e-05	0.000194	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTA3—lung cancer	1.9e-05	0.000194	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—RRM1—lung cancer	1.9e-05	0.000193	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTA3—lung cancer	1.9e-05	0.000193	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CREBBP—lung cancer	1.89e-05	0.000192	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NCOA3—lung cancer	1.87e-05	0.000191	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADCY1—lung cancer	1.82e-05	0.000185	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ABCG2—lung cancer	1.82e-05	0.000185	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.81e-05	0.000184	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AZIN2—lung cancer	1.81e-05	0.000184	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—B4GALT5—lung cancer	1.79e-05	0.000182	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CD—lung cancer	1.79e-05	0.000182	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HPGDS—lung cancer	1.79e-05	0.000182	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ENO2—lung cancer	1.79e-05	0.000182	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—B4GALT5—lung cancer	1.79e-05	0.000182	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPP2R1B—lung cancer	1.78e-05	0.000181	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ALB—lung cancer	1.77e-05	0.00018	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTA4—lung cancer	1.74e-05	0.000177	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTA4—lung cancer	1.74e-05	0.000177	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTT1—lung cancer	1.73e-05	0.000176	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2A6—lung cancer	1.71e-05	0.000174	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GCLC—lung cancer	1.71e-05	0.000174	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTA2—lung cancer	1.7e-05	0.000173	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTA2—lung cancer	1.69e-05	0.000172	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTA1—lung cancer	1.64e-05	0.000167	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTA1—lung cancer	1.63e-05	0.000166	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ENO1—lung cancer	1.62e-05	0.000165	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCC3—lung cancer	1.62e-05	0.000165	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCC3—lung cancer	1.62e-05	0.000164	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKR1C1—lung cancer	1.57e-05	0.00016	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKR1C1—lung cancer	1.56e-05	0.000159	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CB—lung cancer	1.56e-05	0.000159	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTGS2—lung cancer	1.54e-05	0.000157	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ATP5H—lung cancer	1.54e-05	0.000157	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—POMC—lung cancer	1.53e-05	0.000156	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—UGT1A1—lung cancer	1.52e-05	0.000155	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—UGT1A1—lung cancer	1.52e-05	0.000155	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GNG11—lung cancer	1.47e-05	0.000149	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GNG11—lung cancer	1.46e-05	0.000149	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2E1—lung cancer	1.46e-05	0.000148	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NQO1—lung cancer	1.44e-05	0.000147	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALDOA—lung cancer	1.4e-05	0.000142	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALDOA—lung cancer	1.39e-05	0.000142	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PLBD1—lung cancer	1.37e-05	0.00014	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NCOA3—lung cancer	1.36e-05	0.000138	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NCOA3—lung cancer	1.35e-05	0.000138	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTEN—lung cancer	1.35e-05	0.000137	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADCY1—lung cancer	1.32e-05	0.000134	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCG2—lung cancer	1.32e-05	0.000134	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADCY1—lung cancer	1.32e-05	0.000134	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCG2—lung cancer	1.32e-05	0.000134	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—STK11—lung cancer	1.3e-05	0.000132	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HPGDS—lung cancer	1.29e-05	0.000132	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ENO2—lung cancer	1.29e-05	0.000132	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HPGDS—lung cancer	1.29e-05	0.000131	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ENO2—lung cancer	1.29e-05	0.000131	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPP2R1B—lung cancer	1.29e-05	0.000131	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—EP300—lung cancer	1.28e-05	0.000131	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPP2R1B—lung cancer	1.28e-05	0.000131	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTT1—lung cancer	1.26e-05	0.000128	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HSD17B10—lung cancer	1.25e-05	0.000128	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTT1—lung cancer	1.25e-05	0.000128	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GCLC—lung cancer	1.24e-05	0.000126	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP2A6—lung cancer	1.24e-05	0.000126	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2A6—lung cancer	1.24e-05	0.000126	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GCLC—lung cancer	1.24e-05	0.000126	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTP1—lung cancer	1.2e-05	0.000122	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ENO1—lung cancer	1.18e-05	0.00012	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ENO1—lung cancer	1.17e-05	0.000119	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CAT—lung cancer	1.17e-05	0.000119	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CKB—lung cancer	1.17e-05	0.000119	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ABCB1—lung cancer	1.14e-05	0.000116	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—TYMS—lung cancer	1.12e-05	0.000114	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTM1—lung cancer	1.1e-05	0.000112	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CNDP2—lung cancer	1.1e-05	0.000112	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTM2—lung cancer	1.1e-05	0.000112	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MTMR3—lung cancer	1.07e-05	0.000109	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2E1—lung cancer	1.05e-05	0.000107	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP1A1—lung cancer	1.05e-05	0.000107	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NQO1—lung cancer	1.04e-05	0.000106	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NQO1—lung cancer	1.04e-05	0.000106	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PGAM1—lung cancer	1.04e-05	0.000106	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ERCC2—lung cancer	1.04e-05	0.000106	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2A7—lung cancer	9.91e-06	0.000101	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SDC4—lung cancer	9.7e-06	9.87e-05	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CA—lung cancer	9.51e-06	9.68e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—STK11—lung cancer	9.4e-06	9.57e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—STK11—lung cancer	9.38e-06	9.55e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—APOA1—lung cancer	8.98e-06	9.14e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTA3—lung cancer	8.83e-06	8.99e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—RRM1—lung cancer	8.83e-06	8.99e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTP1—lung cancer	8.7e-06	8.86e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTP1—lung cancer	8.68e-06	8.84e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CAT—lung cancer	8.47e-06	8.62e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CAT—lung cancer	8.45e-06	8.6e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—B4GALT5—lung cancer	8.3e-06	8.45e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCB1—lung cancer	8.24e-06	8.38e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCB1—lung cancer	8.22e-06	8.37e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CG—lung cancer	8.2e-06	8.34e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—TYMS—lung cancer	8.09e-06	8.23e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTA4—lung cancer	8.08e-06	8.22e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—TYMS—lung cancer	8.07e-06	8.22e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTM1—lung cancer	8e-06	8.14e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTM1—lung cancer	7.98e-06	8.12e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTA2—lung cancer	7.87e-06	8.01e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—POMC—lung cancer	7.8e-06	7.94e-05	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKT1—lung cancer	7.76e-06	7.9e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CREBBP—lung cancer	7.6e-06	7.74e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTA1—lung cancer	7.6e-06	7.73e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP1A1—lung cancer	7.58e-06	7.72e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP1A1—lung cancer	7.56e-06	7.7e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ERCC2—lung cancer	7.52e-06	7.65e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCC3—lung cancer	7.51e-06	7.65e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ERCC2—lung cancer	7.5e-06	7.64e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKR1C1—lung cancer	7.27e-06	7.41e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CD—lung cancer	7.21e-06	7.34e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALB—lung cancer	7.11e-06	7.24e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—UGT1A1—lung cancer	7.06e-06	7.19e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GNG11—lung cancer	6.81e-06	6.93e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—APOA1—lung cancer	6.5e-06	6.62e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—APOA1—lung cancer	6.49e-06	6.61e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALDOA—lung cancer	6.48e-06	6.6e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NCOA3—lung cancer	6.29e-06	6.41e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CB—lung cancer	6.28e-06	6.39e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTGS2—lung cancer	6.22e-06	6.34e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADCY1—lung cancer	6.12e-06	6.23e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCG2—lung cancer	6.12e-06	6.23e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ENO2—lung cancer	6e-06	6.11e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HPGDS—lung cancer	6e-06	6.11e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.97e-06	6.07e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CG—lung cancer	5.94e-06	6.04e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CG—lung cancer	5.92e-06	6.03e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTT1—lung cancer	5.82e-06	5.93e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GCLC—lung cancer	5.76e-06	5.86e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2A6—lung cancer	5.76e-06	5.86e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—POMC—lung cancer	5.65e-06	5.75e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—POMC—lung cancer	5.64e-06	5.74e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CREBBP—lung cancer	5.5e-06	5.6e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CREBBP—lung cancer	5.49e-06	5.59e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ENO1—lung cancer	5.46e-06	5.56e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTEN—lung cancer	5.43e-06	5.52e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CD—lung cancer	5.22e-06	5.31e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CD—lung cancer	5.21e-06	5.3e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—EP300—lung cancer	5.18e-06	5.27e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALB—lung cancer	5.15e-06	5.25e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALB—lung cancer	5.14e-06	5.23e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2E1—lung cancer	4.89e-06	4.98e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NQO1—lung cancer	4.84e-06	4.93e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CB—lung cancer	4.55e-06	4.63e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CB—lung cancer	4.54e-06	4.62e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTGS2—lung cancer	4.51e-06	4.59e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTGS2—lung cancer	4.5e-06	4.58e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—STK11—lung cancer	4.36e-06	4.44e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTP1—lung cancer	4.04e-06	4.11e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTEN—lung cancer	3.93e-06	4e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CAT—lung cancer	3.93e-06	4e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTEN—lung cancer	3.92e-06	3.99e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CA—lung cancer	3.83e-06	3.9e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCB1—lung cancer	3.82e-06	3.89e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—TYMS—lung cancer	3.75e-06	3.82e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—EP300—lung cancer	3.75e-06	3.82e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—EP300—lung cancer	3.74e-06	3.81e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTM1—lung cancer	3.71e-06	3.78e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP1A1—lung cancer	3.52e-06	3.58e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ERCC2—lung cancer	3.49e-06	3.55e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKT1—lung cancer	3.13e-06	3.18e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—APOA1—lung cancer	3.02e-06	3.07e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CA—lung cancer	2.77e-06	2.82e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CA—lung cancer	2.77e-06	2.82e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CG—lung cancer	2.75e-06	2.8e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—POMC—lung cancer	2.62e-06	2.67e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CREBBP—lung cancer	2.55e-06	2.6e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CD—lung cancer	2.42e-06	2.47e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALB—lung cancer	2.39e-06	2.43e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKT1—lung cancer	2.27e-06	2.31e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKT1—lung cancer	2.26e-06	2.3e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CB—lung cancer	2.11e-06	2.15e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGS2—lung cancer	2.09e-06	2.13e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTEN—lung cancer	1.82e-06	1.86e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—EP300—lung cancer	1.74e-06	1.77e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CA—lung cancer	1.29e-06	1.31e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKT1—lung cancer	1.05e-06	1.07e-05	CbGpPWpGaD
